Mirxes Holding Company Limited Stock Price

SEHK:2629 Community·HK$16.4b Market Cap

0 Narratives written by author
0 Comments on narratives written by author
1 Fair Values set on narratives written by author

Create a narrative

2629 Share Price Performance

HK$59.90

29.90 (99.67%)

HK$59.90

29.90 (99.67%)

HK$59.90

Sun, 16 Nov 25

Share Pricen/a

2629 Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Snowflake Analysis

High growth potential with excellent balance sheet.

1 Risk

1 Reward

View Full Analysis

Mirxes Holding Company Limited Key Details

Last Reported Earnings

Jun 30, 2025

Next Reporting Earnings

n/a

: -0.28
: 53.45%
: -359.78%
: 13.4%

View Full Analysis

About 2629

Founded: 2014
Employees: 347
CEO: Lihan Zhou
WebsiteView website: mirxes.com

Mirxes Holding Company Limited, a micro ribonucleic acid technology company, provides diagnostic solutions for the screening of cancer, cardiovascular, metabolic, and infectious diseases accessible across Singapore and China. The company offers GASTROClear, a blood-based miRNA detection panel consisting of 12 miRNA biomarkers for gastric cancer screening; LUNGClear, a lung cancer screening product candidate; and Fortitude COVID-19 RT-qPCR test kits. It also researches, develops, and manufactures biotechnology, life, and medical science related products. The company was founded in 2014 and is headquartered in Singapore.